• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿毒症患者甲状旁腺结节中的基因异常。

Genetic abnormalities in parathyroid nodules of uremic patients.

作者信息

Chudek J, Ritz E, Kovacs G

机构信息

Department of Urology, Ruprecht-Karls-University, Heidelberg, Germany.

出版信息

Clin Cancer Res. 1998 Jan;4(1):211-4.

PMID:9516973
Abstract

The molecular pathway of autonomous growth of the parathyroid glands in uremic patients is poorly understood. We have analyzed 71 parathyroid lesions from 24 patients with refractory hyperparathyroidism for allelic loss at chromosomes 1, 3, 6, 9, 11, 12, 13, 15, and 17 and at the X chromosome. Microsatellite analysis was performed using 24 highly polymorphic markers. Deletions at chromosomes 1, 3, 6, 11, 12, and 13 and at the X chromosome were detected in only 10 of 67 nodules (15%). No allelic loss of the p16 and p53 tumor suppressor genes or the extracellular calcium receptor gene was found. The X-chromosome inactivation assay revealed a monoclonal pattern in 58% of hyperplastic nodules in females. Our results indicate monoclonal growth in the majority of hyperplastic nodules and suggest that some of these lesions might be considered precursors for adenoma development.

摘要

尿毒症患者甲状旁腺自主生长的分子途径目前尚不清楚。我们分析了24例难治性甲状旁腺功能亢进患者的71个甲状旁腺病变,检测其1、3、6、9、11、12、13、15、17号染色体及X染色体上的等位基因缺失情况。使用24个高度多态性标记进行微卫星分析。在67个结节中,仅10个(15%)检测到1、3、6、11、12、13号染色体及X染色体上的缺失。未发现p16和p53肿瘤抑制基因或细胞外钙受体基因的等位基因缺失。X染色体失活分析显示,女性增生性结节中58%呈单克隆模式。我们的结果表明,大多数增生性结节呈单克隆生长,提示其中一些病变可能被视为腺瘤发生的前体。

相似文献

1
Genetic abnormalities in parathyroid nodules of uremic patients.尿毒症患者甲状旁腺结节中的基因异常。
Clin Cancer Res. 1998 Jan;4(1):211-4.
2
Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11.尿毒症性甲状旁腺功能亢进的进展涉及11号染色体上等位基因的缺失。
J Clin Endocrinol Metab. 1993 Jan;76(1):139-44. doi: 10.1210/jcem.76.1.8421078.
3
Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.尿毒症患者难治性甲状旁腺功能亢进的甲状旁腺:组织病理学及p53蛋白表达分析
Histopathology. 1998 Jul;33(1):46-51.
4
Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia.尿毒症继发性甲状旁腺功能亢进中多发性内分泌肿瘤1型基因的罕见体细胞失活
J Clin Endocrinol Metab. 2000 Nov;85(11):4113-7. doi: 10.1210/jcem.85.11.6950.
5
Microsatellite instability and loss of heterozygosity in primary and secondary proliferative lesions of the parathyroid gland.
Lab Invest. 1999 Sep;79(9):1051-8.
6
Phosphatemia is related to chromosomal aberrations of parathyroid glands in patients with hyperparathyroidism.甲状旁腺功能亢进患者的血磷异常与甲状旁腺的染色体畸变有关。
J Nephrol. 2007 Mar-Apr;20(2):164-72.
7
Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.肾乳头状细胞癌患者多灶性乳头状肿瘤独立起源的分子遗传学证据。
Clin Cancer Res. 2005 Oct 15;11(20):7226-33. doi: 10.1158/1078-0432.CCR-04-2597.
8
Accumulation of allelic changes at chromosomes 7p, 18q, and 2 in parathyroid lesions of uremic patients.
Lab Invest. 2001 Apr;81(4):527-33. doi: 10.1038/labinvest.3780261.
9
[Chromosome abnormalities in hyperparathyroidism: utility of comparative genomic hybridization in the study of parathyroid hyperplasias].[甲状旁腺功能亢进症中的染色体异常:比较基因组杂交技术在甲状旁腺增生研究中的应用]
Nefrologia. 2003;23 Suppl 2:2-6.
10
Molecular evidence supporting field effect in urothelial carcinogenesis.支持尿路上皮癌发生中场效应的分子证据。
Clin Cancer Res. 2005 Sep 15;11(18):6512-9. doi: 10.1158/1078-0432.CCR-05-0891.

引用本文的文献

1
Parathyroid carcinoma in the setting of tertiaryhyperparathyroidism after renal transplant.肾移植后三发性甲状旁腺功能亢进背景下的甲状旁腺癌
Endocr Pathol. 2014 Dec;25(4):433-5. doi: 10.1007/s12022-014-9336-5.
2
Molecular genetics of parathyroid disease.甲状旁腺疾病的分子遗传学。
World J Surg. 2009 Nov;33(11):2224-33. doi: 10.1007/s00268-009-0022-6.